Anticoagulants and antiplatelet agents and the risk of development and recurrence of chronic subdural haematomas
2009 (English)In: Journal of clinical neuroscience, ISSN 0967-5868, E-ISSN 1532-2653, Vol. 16, no 10, 1287-1290 p.Article in journal (Refereed) Published
Seventy-one patients from northern Sweden were diagnosed with chronic subdural haematomas (CSDH) and treated at the Department of Neurosurgery at Umeå University Hospital over 12 months. Fifty-four patients with CSDH had a history of head trauma (trauma group), while 17 patients had no previous head trauma (non-trauma group). In the non-trauma group 71% of patients were treated with anticoagulants or antiplatelet aggregation agents (AAA) compared to 18% in the trauma group. Considering only AAA, 59% of the non-trauma patients were treated with these drugs versus 17% of patients in the trauma group. The recurrence rate for all patients was 17%. These findings confirm that the use of anticoagulants and AAA is over-represented in patients with non-traumatic CSDH. In our study, recurrence was not associated with previous use of anticoagulants or AAA.
Place, publisher, year, edition, pages
2009. Vol. 16, no 10, 1287-1290 p.
IdentifiersURN: urn:nbn:se:umu:diva-34703DOI: 10.1016/j.jocn.2009.01.001PubMedID: 19564115OAI: oai:DiVA.org:umu-34703DiVA: diva2:323879